The Best Target
The Best Chemical

AI platform based novel drug development specialist for rare and refractory diseases.

AI platform based novel drug development specialist for rare and refractory diseases Transforming Big Data To Healthcare

NEXT
PREV

Transforming
Big Data to Healthcare

We will create a global biotech that can improve the quality of life and give greater happiness to patients suffering from diseases by developing treatments for refractory and rare diseases based on the development of various healthcare platforms through analysis of disease and compound big data.

pipeline

New drug development company with excellent clinical pipeline.

VIEW MORE

TECHNOLOGY

AI platform based novel drug development specialist for rare and refractory diseases.

VIEW MORE

MERIT

Big data and AI-based new drug development system.

VIEW MORE

  • NO.1

    First phase 1 clinical trial in Korea using an AI-based drug development platform.

  • 240 million

    Big Data
    240 million

  • 9
    Chemiverse Platform

    Best Target 4
    Best Chemical 5

  • 10
    R&D Pipeline

    Two clinical stage
    (1 Candidate, 2 Lead, 1 Hits,
    4 Indications)

News &
Notice

Pharos iBio will inform you of the latest news and information.

VIEW MORE
Press release

The Chemiverse platform: AI and big data-based drug discovery and deve..

The Chemiverse platform: AI and big data-based drug discovery and developmentChemiverse provides a quicker route to ‘the..

2021.05.04